The latest price target for Sabra Health Care REIT (NASDAQ:SBRA) was reported by Scotiabank on October 11, 2024. The analyst firm set a price target for $18.00 expecting SBRA to fall to within 12 months (a possible -0.99% downside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Sabra Health Care REIT (NASDAQ:SBRA) was provided by Scotiabank, and Sabra Health Care REIT maintained their sector perform rating.

The last upgrade for Sabra Health Care REIT Inc happened on September 13, 2024 when Citigroup raised their price target to $20. Citigroup previously had a neutral for Sabra Health Care REIT Inc.

The last downgrade for Sabra Health Care REIT Inc happened on October 17, 2023 when BMO Capital changed their price target from N/A to $16 for Sabra Health Care REIT Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sabra Health Care REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sabra Health Care REIT was filed on October 11, 2024 so you should expect the next rating to be made available sometime around October 11, 2025.

While ratings are subjective and will change, the latest Sabra Health Care REIT (SBRA) rating was a maintained with a price target of $17.00 to $18.00. The current price Sabra Health Care REIT (SBRA) is trading at is $18.18, which is out of the analyst’s predicted range.